Acasă › Cancer de sân › Michigan › Ann Arbor
Studii clinice pentru Cancer de sân în Ann Arbor, MI
27 studii pentru Cancer de sân caută participanți în și în jurul orașului Ann Arbor (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
În curs de recrutareFaza 3
- University of Michigan, Ann Arbor
A Study of PHST001 in Advanced Solid Tumors
În curs de recrutareFaza 1
- University of Michigan Rogel Cancer Center, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · La 7 mi distanță
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · La 7 mi distanță
- și încă 4
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
În curs de recrutareFaza 1/2
- University of Michigan, Ann Arbor
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
În curs de recrutareFaza 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
În curs de recrutareFaza 3
- Clinical Trial Site, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
În curs de recrutareFaza 1
- University of Michigan, Ann Arbor
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
În curs de recrutareFaza 3
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
În curs de recrutareStudiu observațional
- Trinity Health, Ann Arbor
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · La 7 mi distanță
- și încă 6
E-Mindfulness Approaches for Living After Breast Cancer
În curs de recrutareFaza 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
În curs de recrutareFaza 2Voluntari sănătoși bineveniți
- University of Michigan Rogel Cancer Center, Ann Arbor
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
În curs de recrutareFaza 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
În curs de recrutareFaza 1
- University of Michigan, Ann Arbor
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
În curs de recrutareFaza 4
- University of Michigan Rogel Cancer Center, Ann Arbor
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
În curs de recrutareFaza 2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
În curs de recrutareFaza 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · La 7 mi distanță
- și încă 5
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
În curs de recrutareFaza 1/2
- Trinity Health, Ypsilanti · La 7 mi distanță
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
În curs de recrutare
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
În curs de recrutare
- University of Michigan Comprehensive Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Ann Arbor
The Cancer of the Pancreas Screening-5 CAPS5)Study
În curs de recrutareFaza 3
- University of Michigan, Ann Arbor
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
În curs de recrutareFaza 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · La 7 mi distanță
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
În curs de recrutareFaza 1/2
- University of Michigan, Ann Arbor
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
În curs de recrutareFaza 1
- University of Michigan, Ann Arbor
CtDNA Based MRD Testing for NAC Monitoring in TNBC
În curs de recrutareStudiu observațional
- Trinity Health-Michigan, Ypsilanti · La 7 mi distanță
Studii pentru Cancer de sân în alte orașe
- New York City, NY136 studii
- Houston, TX126 studii
- Boston, MA112 studii
- Nashville, TN81 studii
- Los Angeles, CA73 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Queens, NY64 studii
- Durham, NC64 studii
- Chicago, IL59 studii
- Philadelphia, PA56 studii
- Dallas, TX55 studii
Alte studii în Ann Arbor
- Cancer de prostată27 studii
- Cancer pulmonar cu celule non-pătrate26 studii
- Cancer (toate tipurile)25 studii
- Cancer pulmonar23 studii
- Cancer colorectal23 studii
- Insuficiență cardiacă22 studii
- Leucemie mieloasă acută17 studii
- Boli cardiovasculare16 studii
- Cancer pancreatic14 studii
- Melanom12 studii
- Accident vascular cerebral12 studii
- Carcinom cu celule scuamoase de cap și gât12 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.